FMO5 and cancer: MDSCs isolated from both tumor-bearing mice and cancer patients demonstrated significant immunosuppressive effects on T cell proliferation and production of interferon-γ (IFNγ), while MDSCs from NADPH oxidase-deficient mice lost the ability to suppress T cell responses [68,70,71].